Alnylam Pharmaceuticals Inc
NASDAQ:ALNY

Watchlist Manager
Alnylam Pharmaceuticals Inc Logo
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Watchlist
Price: 245.44 USD 2.75% Market Closed
Market Cap: 31.7B USD
Have any thoughts about
Alnylam Pharmaceuticals Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Alnylam Pharmaceuticals Inc

Current Assets 3.4B
Cash & Short-Term Investments 2.8B
Receivables 353.9m
Other Current Assets 221.3m
Non-Current Assets 849.6m
PP&E 703.4m
Other Non-Current Assets 146.2m
Current Liabilities 1.2B
Accounts Payable 70.8m
Accrued Liabilities 988.3m
Other Current Liabilities 161.5m
Non-Current Liabilities 3B
Long-Term Debt 1B
Other Non-Current Liabilities 1.9B

Balance Sheet
Alnylam Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
75
181
194
645
420
547
497
820
866
813
Cash Equivalents
75
181
194
645
420
547
497
820
866
813
Short-Term Investments
622
900
433
1 045
664
989
1 378
1 616
1 326
1 627
Total Receivables
40
8
23
34
19
43
602
199
238
328
Accounts Receivables
40
8
23
34
19
43
69
125
206
228
Other Receivables
0
0
0
0
0
0
534
73
32
100
Inventory
0
0
0
0
24
56
75
86
129
89
Other Current Assets
10
17
22
40
74
80
63
88
133
126
Total Current Assets
746
1 105
672
1 765
1 201
1 716
2 615
2 809
2 692
2 983
PP&E Net
22
28
115
182
321
646
707
734
739
726
PP&E Gross
22
28
115
182
321
646
707
734
739
726
Accumulated Depreciation
46
52
61
67
80
76
104
140
174
223
Long-Term Investments
280
252
325
14
0
0
0
0
0
0
Other Long-Term Assets
32
2
152
34
53
33
86
101
116
121
Total Assets
1 080
N/A
1 387
+28%
1 263
-9%
1 995
+58%
1 575
-21%
2 395
+52%
3 407
+42%
3 643
+7%
3 546
-3%
3 830
+8%
Liabilities
Accounts Payable
15
17
55
28
60
50
52
73
98
56
Accrued Liabilities
24
29
42
72
113
225
393
436
587
755
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
57
17
35
44
7
78
141
187
82
158
Total Current Liabilities
95
62
132
144
180
353
585
696
768
968
Long-Term Debt
0
0
150
30
30
0
191
676
1 017
1 021
Other Liabilities
48
60
61
54
63
604
1 614
1 684
1 920
2 062
Total Liabilities
143
N/A
122
-15%
343
+181%
228
-33%
273
+19%
956
+251%
2 391
+150%
3 055
+28%
3 705
+21%
4 051
+9%
Equity
Common Stock
1
1
1
1
1
1
1
1
1
1
Retained Earnings
957
1 247
1 657
2 148
2 841
3 727
4 585
5 438
6 569
7 010
Additional Paid In Capital
1 843
2 506
2 610
3 948
4 175
5 201
5 644
6 059
6 455
6 811
Unrealized Security Profit/Loss
0
0
0
0
0
33
32
34
42
31
Other Equity
49
4
33
34
33
4
11
1
2
8
Total Equity
936
N/A
1 265
+35%
920
-27%
1 766
+92%
1 302
-26%
1 439
+10%
1 016
-29%
588
-42%
158
N/A
221
-39%
Total Liabilities & Equity
1 080
N/A
1 387
+28%
1 263
-9%
1 995
+58%
1 575
-21%
2 395
+52%
3 407
+42%
3 643
+7%
3 546
-3%
3 830
+8%
Shares Outstanding
Common Shares Outstanding
77
85
86
100
101
112
116
120
124
126

See Also

Discover More